S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

GoHealth Price Target, Predictions & Analyst Ratings

-0.23 (-6.07%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
2.08 million shs
Average Volume
2.35 million shs
Market Capitalization
$1.14 billion
P/E Ratio
Dividend Yield

GoHealth (NASDAQ:GOCO) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Based on 7 Analyst Ratings

Analyst Price Target Consensus

183.24% Upside

High PT$20.00
Average PT$10.08
Low PT$5.00
11/28/20 to 11/28/21
1 Month Ago
10/29/20 to 10/29/21
3 Months Ago
8/30/20 to 8/30/21
1 Year Ago
11/29/19 to 11/28/20
Consensus Rating
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
10 Buy rating(s)
4 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$10.08$15.33$15.33$21.22
Price Target Upside183.24% Upside71.48% Upside71.48% Upside39.84% Upside
Get GoHealth Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GOCO and its competitors with MarketBeat's FREE daily newsletter.

Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GoHealth (NASDAQ:GOCO) vs. Its Competitors

TypeGoHealthFinance CompaniesS&P 500
Consensus Rating Score
Consensus RatingHoldBuyBuy
Price Target Upside183.24% Upside25.58% Upside12.00% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
Community Rating
Outperform Votes
Underperform Votes
Avg. Outperform Votes
Avg. Underperform Votes
Avg. Outperform Votes
Avg. Underperform Votes

GoHealth (NASDAQ:GOCO) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/15/2021Credit Suisse Group
Lower Price TargetNeutral$7.00 ➝ $6.00+35.44%
11/11/2021Morgan Stanley
Lower Price TargetEqual Weight$13.00 ➝ $5.50+20.35%
11/10/2021Royal Bank of Canada
Lower Price TargetOutperform$17.00 ➝ $10.00+130.95%
DowngradeOverweight ➝ Equal Weight$10.00 ➝ $5.00+7.53%
8/12/2021Cantor Fitzgerald
S. Halper
Reiterated RatingOverweight
8/12/2021Raymond James
DowngradeOutperform ➝ Market Perform
Tobey Sommer
Lower Price TargetBuy ➝ Buy$26.00 ➝ $20.00+73.16%
11/12/2020Evercore ISI
Lower Price TargetOutperform$27.00 ➝ $25.00+125.02%
8/11/2020William Blair
A. Klauber
Initiated CoverageOutperform
8/10/2020Truist Financial
Initiated CoverageBuy
8/10/2020Bank of America
Initiated CoverageBuy$22.00+27.54%
8/10/2020The Goldman Sachs Group
Initiated CoverageBuy$21.00+21.74%
(Data available from 11/28/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)

GoHealth (NASDAQ:GOCO) Analyst Ratings Frequently Asked Questions

What is GoHealth's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for GoHealth stock is Hold based on the current 4 hold ratings and 3 buy ratings for GOCO. The average twelve-month price target for GoHealth is $10.08 with a high price target of $20.00 and a low price target of $5.00. Learn more on GOCO's analyst rating history

Do Wall Street analysts like GoHealth more than its competitors?

Analysts like GoHealth stock less than the stock of other Finance companies. The consensus rating for GoHealth is Hold while the average consensus rating for finance companies is Buy. Learn more on how GOCO compares to other companies

Do MarketBeat users like GoHealth more than its competitors?

MarketBeat users like GoHealth stock more than the stock of other Finance companies. 70.37% of MarketBeat users gave GoHealth an outperform vote while finance companies recieve an average of 62.58% outperform votes by MarketBeat users.

Is GoHealth being downgraded by Wall Street analysts?

Over the previous 90 days, GoHealth's stock had 1 downgrade by analysts.

Does GoHealth's stock price have much upside?

According to analysts, GoHealth's stock has a predicted upside of 57.33% based on their 12-month price targets.

What analysts cover GoHealth?

GoHealth has been rated by Barclays, Credit Suisse Group, Morgan Stanley, and Royal Bank of Canada in the past 90 days.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.